Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Found 2347 studies with search of: | "Lymphoma" |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Recruiting |
Trial for the Treatment of Newly Diagnosed Mature B-Cell Acute Lymphoblastic Leukemia (B-ALL), Burkitt's Non-Hodgkin's Lymphoma (NHL) and Other High-Grade Lymphoma in Adults
|
||||
2 | Completed |
Combination Chemotherapy and Monoclonal Antibody Therapy Followed by Vaccine Therapy in Treating Patients With Mantle Cell Lymphoma
|
||||
3 | Recruiting |
Phase 1b Lymphoma Study of AMG 655 in Combination With Bortezomib or Vorinostat
|
||||
4 | Recruiting |
Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell Lymphomas
|
||||
5 | Recruiting |
Immunotherapy in Peripheral T Cell Lymphoma - the Role of Alemtuzumab in Addition to Dose Dense CHOP
|
||||
6 | Recruiting |
First-Line R-CVP vs R-CHOP Induction Immunochemotherapy for Indolent Lymphoma and R Maintenance.
|
||||
7 | Withdrawn |
Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma
|
||||
8 | Recruiting |
Lenalidomide Therapy for Patients With Relapsed and/or Refractory, Peripheral T-Cell Lymphomas
|
||||
9 | Active, not recruiting |
Intensive Chemotherapy and Rituximab in the Treatment of Burkitt Lymphoma
|
||||
10 | Completed |
Phase II Safety and Efficacy Study of Single-Agent AT-101 in Patients With Relapsed or Refractory B-Cell Malignancies
|
||||
11 | Withdrawn |
Antineoplaston Therapy in Treating Patients With Mantle Cell Lymphoma
|
||||
12 | Recruiting |
A Phase I Clinical Trial to Assess the Safety of SyB L-0501 in Combination With Rituximab to Patients With Aggressive B-Cell Non-Hodgkin's Lymphoma
|
||||
13 | Completed |
VELCADE® (Bortezomib) With Rituximab in Subjects With Relapsed or Refractory Indolent B-Cell Lymphoma
|
||||
14 | Recruiting |
Oral Clofarabine for Relapsed/Refractory Non-Hodgkin Lymphomas
|
||||
15 | Recruiting |
A Study of the Monoclonal Antibody CT-011 in Diffuse Large B-Cell Lymphoma Following Autologous Stem Cell Transplantation
|
||||
16 | Recruiting |
A Study Of Pharmacokinetics, Whole Body And Organ Dosimetry, And Biodistribution Of Fission-Derived Iodine I 131 Tositumomab (BEXXAR®) For Patients With Previously Untreated Or Relapsed Follicular Or Transformed Non-Hodgkin's Lymphoma
|
||||
17 | Active, not recruiting |
Active Specific Immunotherapy for Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype Antigen Vaccines
|
||||
18 | Completed |
Dose Ranging Trial for Pixantrone in the FND-R Variant Regimen in Indolent Non-Hodgkin's Lymphoma
|
||||
19 | Terminated |
Comparative Trial for Pixantrone in Combination With Rituximab in Indolent Non-Hodgkin's Lymphoma
|
||||
20 | Completed |
Pilot Protocol for the Treatment of Patients With Small Non-Cleaved and Diffuse Large Cell Lymphomas
|
Previous Page | Studies Shown (1-20) | Next (21-40) |